Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | CL | PG |
|---|---|---|
| Price | $85.78 | $146.98 |
| Change today | ▼ 0.18% | ▼ 0.28% |
| Market cap | $68.38B | $341.39B |
| Return, 3 months | -6.1% | -2.6% |
| Return, year to date | +10.5% | +4.8% |
| Return, 1 year | +8.4% | -0.7% |
| P/E (TTM) | 33.8 | 22.2 |
| P/B | 289.8 | 6.4 |
| P/E percentile vs own 5y | 70th | 14th |
| Dividend yield | 2.44% | 2.90% |
| Revenue growth (YoY, latest qtr) | +4.9% | +1.5% |
| Net profit growth (YoY) | -7.0% | -15.0% |
| Gross margin | 60.4% | 50.2% |
| Operating margin | 19.3% | 22.7% |
| Net margin | 9.7% | 18.1% |
| Return on equity | 434.5% | 30.1% |
| Analyst target vs. price | +19.7% | +9.4% |
| Analyst buy share | 89% | 56% |
| RSI (14) | 41 | 58 |
| 30-day volatility | 15.7% | 13.8% |
| Max drawdown, 1 year | -17.0% | -15.5% |
| Trend read | Strong downtrend | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.